These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Microvascular complications of diabetes. He Z; King GL Endocrinol Metab Clin North Am; 2004 Mar; 33(1):215-38, xi-xii. PubMed ID: 15053904 [No Abstract] [Full Text] [Related]
5. Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy. Chiarelli F; Mansour M; Verrotti A Diabetes Nutr Metab; 2000 Aug; 13(4):192-9. PubMed ID: 10961486 [No Abstract] [Full Text] [Related]
6. Hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells. Kreisberg JI Lab Invest; 1992 Oct; 67(4):416-26. PubMed ID: 1434526 [No Abstract] [Full Text] [Related]
7. [Diabetic microangiopathy: does a genetic susceptibility HLA-correlated exist?]. Scaldaferri E; Devidè A Minerva Endocrinol; 1985; 10(2):115-24. PubMed ID: 3906376 [No Abstract] [Full Text] [Related]
8. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502 [TBL] [Abstract][Full Text] [Related]